Raday Gileadinsider trades

In SEC Form 4 filings, Raday Gilead is listed as Chief Operating Officer of RedHill Biopharma Ltd. (RDHL). In the last 90 days, Raday Gilead sold $1.4K of RedHill Biopharma Ltd. (RDHL) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
RDHLRedHill Biopharma Ltd.	Chief Operating Officer	2	Oct 6

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-06

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RDHLRedHill Biopharma Ltd.	Oct 1	Oct 6	S	14,310,000	$0.00	Sale −$1,431	176,910,000	No	Form 4
RDHLRedHill Biopharma Ltd.	Oct 1	Oct 6	M · derivative	27,560,000	$0.00	$0	131,690,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.